UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023404
Receipt number R000026818
Scientific Title Study about impact of dilution of rocuronium bromide on onset time of neuromuscular blockade
Date of disclosure of the study information 2016/08/01
Last modified on 2019/07/12 16:31:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study about impact of dilution of rocuronium bromide on onset time of neuromuscular blockade

Acronym

Study about impact of dilution of rocuronium bromide on onset time of neuromuscular blockade

Scientific Title

Study about impact of dilution of rocuronium bromide on onset time of neuromuscular blockade

Scientific Title:Acronym

Study about impact of dilution of rocuronium bromide on onset time of neuromuscular blockade

Region

Japan


Condition

Condition

patients undergoing general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Our hypothesis is that dilution of rocuronium bromide with 0.9% saline (increased volume, same dosage) can change its distribution and consiquently make onset time faster than undiluted solution.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Onset time of neuromuscular blockade

Key secondary outcomes

Duration 25% (time from the start of injection of NMBA until the T1 in the TOF or the single twitch has recovered to 25% of the final value), Duration TOF 0.9 (the time from start of injection of the NMBA until recovery of the TOF ratio to 0.9), rocuronium-induced withdrawal movement


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Group 1 receive undiluted rocuronium 0.6 mg kg-1 over 5 seconds

Interventions/Control_2

Group 2 receive diluted rosuronium 0.6 mg kg-1 in 20 ml 0.9% saline over 5 seconds

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with an ASA physical status 1 or 2, scheduled for elective surgery under general anesthesia using rocuronium and supraglottic device at the Ryukyu university hospital are recruited.

Key exclusion criteria

Patients with severe hepatic, renal, or cardiovascular disease, neuromuscular disease, a history of rocuronium allergy, body mass index >=25 kg/m2 were excluded.

Target sample size

106


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Misuzu Hayashi

Organization

Ryukyu university hospital

Division name

Department of anesthesiology

Zip code


Address

Uehara 207, Nishihara, Nakagami, Okinawa 903-0125

TEL

098-895-1336

Email

koba_shu1982@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Misuzu Hayashi

Organization

Ryukyu university hospital

Division name

Department of anesthesiology

Zip code


Address

Uehara 207, Nishihara, Nakagami, Okinawa 903-0125

TEL

098-895-1336

Homepage URL


Email

koba_shu1982@yahoo.co.jp


Sponsor or person

Institute

Ryukyu university

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 06 Month 28 Day

Date of IRB

2016 Year 06 Month 01 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 30 Day

Last modified on

2019 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026818


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name